Personality disorders in the primary care setting

Nurse Practitioner

Volumn 25, Issue 12, 2000, Pages 40-63

  Norton, John W ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; NURSE PRACTITIONER; NURSING; NURSING ASSESSMENT; PERSONALITY DISORDER; PRIMARY HEALTH CARE; REVIEW;

HUMANS; NURSE PRACTITIONERS; NURSING ASSESSMENT; PERSONALITY DISORDERS; PRIMARY HEALTH CARE;

EID: 0442302261     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/20006205-200025120-00004     Document Type: Article

References (26)

1. Dhossche DM, Shevitz SA: Assessment and importance of personality disorders in medical patients: An update. South Med J 1999;92(6):546-556.
2. Diagnostic and statistical manual of mental disorders, fourth edition. Washington, D.C.: American Psychiatric Association, 1994;629-735.
3. Lenzenweger MF: Stability and change in personality disorder features: The longitudinal study of personality disorders. Arch Gen Psychiatry 1999;56(11): 1009-1015.
4. Comtois KA, Cowley DS, Dunner DI., et al.: Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety. J Clin Psychiatry 1999;60(11):752-58.
5. Tyrer P, Seivewright N, Seivewright H: Long-term outcome of hypochondriacal personality disorder. J Psychosom Res 1999;46(2): 177-135.
6. Coid JW: Aetiological risk factors for personality disorders. Br J Psychiatry 1999;174:530-538.
7. Battaglia M, Fossati A, Torgersen S, et al.: A psychometric-genetic study of schizotypal disorder. Schizo Res 1999;37(1):53-64.
8. Fossati A, Madeddu F, Maffei C: Borderline personality disorder and childhood sexual abuse: A meta-analytic study. J Personal Disord 1999;13(3):268-80.
9. Siever LJ, Buschsbaum MS, New AS, et al.: D,1-fenfluramine response in impulsive personality disorder assessed with [ 18FJ fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999;20(5):413-423.
10. Herpertz SC, Kunert HJ, Schwenger UB, et al.: Affective responsiveness in borderline personality disorder: A psychophysiological approach. Am J Psychiatry 1999;156(10): 1550-1556.
11. Mindus P, Edman G, Andreewitch S: A prospective, long-term study of personality traits in patients with intractable obsessional illness treated by capsu- lotomy. Acta Psychiatr Scand 1999;99(1):40-50.
12. Aitken L, Simpson S, Burns A: Personality change in dementia. Int Psychogeriatr 1999; 11 (3):263-271.
13. Gabbard GO: Psychotherapy of personality disorders. J Psychother Pract Res 2000;9(1):1-6.
14. Meares R, Stevenson J, Comerford A: Psychotherapy with borderline patients: I. A comparison between treated and untreated cohorts. Aust N Z J Psychiatry 1999;33(4):467-472.
15. Perry JC, Banon E, Ianni F: Effectiveness of psychotherapy for personality disorders. Am J Psychiatry 1999; 156(9): 1312-1321.
16. Flood C: What are personality disorders and are they treatable? Br J Nurs 1999;8(4):231-234.
17. Roller B, Nelson V: Group psychotherapy treatment of borderline personalities. Int J Group Psychother 1999;49(3):369-385.
18. Bateman A, Fonagy P: Effectiveness of partial hospitalization in the treatment of borderline personality disorder: A randomized controlled trial. Am J Psychiatry 1999; 156(10): 1563-1569.
19. Wilberg T, Urnes O, Friis S, et al.: One-year follow-up of day treatment for poorly functioning patients with personality disorders. Psychiatr Serv 1999; 50(10): 1326-1330.
20. Stevenson J, Meares R: Psychotherapy with borderline patients: II. A preliminary cost benefit study. Aust NZI Psychiatry 1999;33(4):473-477.
21. Ekselius L, Von Knorring L: Changes in personality traits during treatment with sertraline or citalopram. Br J Psychiatry 1999;174:444-448.
22. Hollander E: Managing aggressive behavior in patients with obsessive-com- pulsive disorder and borderline personality disorder. J Clin Psychiatry 1999;60(suppl 15):38-44.
23. Pinto OC, Askiskal HS: Lamotriginc as a promising approach to borderline personality: An open case series without concurrent DSM-IV major mood disorder. J Affect Disord 1998;51(3):333-343.
24. Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, et al.: Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: An open-label trial. J Clin Psychiatry 1999;60(9):598-603.
25. Chengappa KN, Ebeling T, Kang JS, et al.: Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60(7):477-484.
26. Schulz SC, Camlin KL, Berry SA, et al.: Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 1999;46(10): 1429-1435.